CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Oct. 31, 2025	Oct. 31, 2024	Oct. 31, 2023
Net revenue:
Net revenue	$ 6,948	$ 6,510	$ 6,833
Costs and expenses:
Cost of revenue	3,305	2,975	3,368
Research and development	455	479	481
Selling, general and administrative	1,709	1,568	1,634
Total costs and expenses	5,469	5,022	5,483
Income from operations	1,479	1,488	1,350
Interest income	62	80	51
Interest expense	(112)	(96)	(95)
Other income (expense), net	6	49	33
Income before taxes, as reported	1,435	1,521	1,339
Provision for income taxes	132	232	99
Net Income	$ 1,303	$ 1,289	$ 1,240
Net income per share:
Net income per share - basic	$ 4.59	$ 4.44	$ 4.22
Net income per share - diluted	$ 4.57	$ 4.43	$ 4.19
Weighted Averge Shares Used In Computing Net Income Per Share
Basic (in shares)	284	290	294
Diluted (in shares)	285	291	296
Products
Net revenue:
Net revenue	$ 4,944	$ 4,672	$ 5,051
Costs and expenses:
Cost of revenue	2,237	2,024	2,428
Services and Other
Net revenue:
Net revenue	2,004	1,838	1,782
Costs and expenses:
Cost of revenue	$ 1,068	$ 951	$ 940